Avadel, marked by consistent patient adoption of LUMRYZ and overwhelmingly positive feedback from both patients ...
"As we move into 2025, we are building on this momentum with a refined commercial strategy to increase demand for and persistency on, LUMRYZ, with the primary goal of enhancing the overall LUMRYZ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback